Since human blue nevi and derived melanomas situated in the dermis also frequently harbor Gnaq/11 mutations [4, 32], our results support the idea that cross-signaling between oncogenic Gnaq/11 and RTKs could represent a molecular driver of the growth of melanocytic cells in this specific anatomical location. The gene discussed is GNAQ; the disease is melanoma.